Barrier masks are designed to protect from bacteria and other air-borne disease particles. Barrier masks are worn by the general public, industry workers, laboratory personnel, sanitation workers, airport security personnel, medical professional, police and security personnel, and other end users for safety and hygiene purposes. Barrier masks are available in various designs, sizes, and colors and offer high protection levels. In addition, barrier masks are highly comfortable and low air resistance to decrease irritating the wearer. All these factors are expected to increase the demand for barrier masks across the world during the forecast period.
Increasing dry climate, rising infrastructural activities, and releasing impurities through industrial processes cause dust in the air. This is likely to boost the demand for barrier masks.
Other factors, such as rising healthcare expenditure and number of surgical procedures and surgeries, expanding healthcare sector, greater availability of products, and higher awareness regarding health benefits associated with barrier masks are driving the barrier masks market during the forecast period
In addition, increasing health issues such as severe asthma, throat irritation, lung diseases, and airway diseases is expected to fuel the demand for barrier masks across the world during the forecast period
Growing fluctuation in raw material prices is expected to hamper the market growth during the forecast period
There is an increasing preference for disposable medical devices, which include face masks, as disposable devices reduce the probability of acquiring hospital-acquired infections and other infectious diseases such as Ebola, COVID-19, swine flu, etc. All these factors are expected to create huge opportunities for the barrier mask market during the forecast period.
Evolution of the e-Commerce sector has created huge opportunities for producers and distributors in the industry
The global barrier masks market can be segmented based on type, material, size, end-user, distribution channel, and region
Based on type, the barrier masks market has been segmented into disposable and reusable.
Based on material, the market has been segmented into plastic, silicone, cotton, and others
Based on the size, the market has been segmented into small, medium, and large.
Based on end-user, the market has been classified into residential, commercial, and industrial. The commercial segment has been further segmented into healthcare & pharmaceutical, chemical & petrochemical, and others.
Based on the distribution channel, the barrier masks market can be divided into online and offline. The online segment is divided into company-owned websites and e-Commerce retailers. The offline segment is further divided into hypermarkets/supermarkets, pharmaceutical stores, departmental stores, and others.
Based on region, the global market can be divided into North America (U.S, Canada, and Rest of North America), Europe (U.K, Germany, France, Italy, and Rest of Europe), Asia Pacific (Japan, India, China, and Rest of Asia Pacific), Middle East & Africa (GCC Countries, South Africa, and Rest of the Middle East & Africa), and South America (Brazil and Rest of South America)
North America is expected to hold a major market share, followed by Europe. Factors, such as the presence of a large number of major players and growing health awareness across the region, is expected to accelerate the barrier masks market in both the region.
The Asia Pacific is expected to grow at the fastest rate during the forecast period, owing to hay fever, air heavy pollution, and deadly pandemic called coronavirus and others, and increasing industrialization. In addition, growing safety regulations by the government in developing countries such as India and China is likely to increase the demand for the barrier masks market among different end-users during the forecast period.
Key players operating in the global barrier masks market include HAL Allergy B.V., Shionogi & Co., Ltd., Sanofi, Teva Pharmaceutical Industries Ltd., ICB PHARMA, Merck & Co., Inc., Allergy Therapeutics,Torii Pharmaceutical Co., Ltd, Ergomed Plc, Circassia, Stallergenes Greer, Merck KGaA, ASIT biotech, Trio Lifescience Private Limited., and Bayer AG, among others
These market players are focused on the adoption of business strategies such as mergers & acquisitions and geographical expansion. Furthermore, market players are more focused on product development and enhancement to have a competitive advantage over others.
By Distribution Channel